MM and KRAS pathways were enriched (FDR < 0.25) as shown by GSEA based on the fold change of expression in NSD2 High vs. Low cells (Supplementary Fig. 1d) (see the “Methods” section for details). This evidence concerns the gene KRAS and Miyoshi myopathy.